AgJunction Settles with Raven in Patent Infringement Suit

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
133
AgJunction Settles with Raven in Patent Infringement Suit

Hiawatha, July 11, 2018 (GLOBE NEWSWIRE) -- AgJunction Inc. (TSX: AJX), a leader in advanced guidance and autosteering, announced today that it has settled a patent infringement lawsuit it filed against Raven Industries, Inc. (“Raven”) in January of this year. The suit alleged Raven products violated three AgJunction patents related to automated mechanical steering, implement steering and system calibration technologies. Raven and AgJunction announce that they have reached a mutually agreeable no-fault business solution, whereby Raven is granted a nonexclusive license to a significant portion of AgJunction’s extensive patent portfolio, and the litigation is resolved.  Under the agreement, both companies will continue to pursue their varied commercial interests.  “We are very pleased to announce this agreement with Raven to license certain of our technology; commercialization of our patent portfolio is a vital component of our corporate strategy and central to the success of our business and that of our partners,” said Bob Barjesteh, vice president of intellectual property and general counsel for AgJunction. “Licensing these patents to Raven substantiates the strength of our industry-leading intellectual property portfolio.”

  About AgJunction AgJunction Inc. is a global leader of advanced guidance and autosteering solutions for precision agriculture applications. Its technologies are critical components in over 30 of the world’s leading precision Ag manufacturers and solution providers and it holds over 130 fundamental steering and machine control patents. AgJunction markets its solutions under leading brand names including Novariant, Outback Guidance® and Satloc® and is committed to advance its vision by bringing affordable hands-free farming to every farm, regardless of terrain or size. AgJunction is headquartered in Hiawatha, Kansas, with facilities in Silicon Valley, Arizona, Canada, and Australia, and is listed on the Toronto Stock Exchange (TSX) under the symbol “AJX.” For more information, please go to www.agjunction.com   Reader Advisory and Note Regarding Forward Looking Information This press release contains forward-looking information and forward-looking statements (collectively, "forward-looking information") within the meaning of applicable securities laws and is based on the expectations, estimates and projections of management of AgJunction as of the date of this news release, unless otherwise stated. The use of any of the words "expect," "anticipate," "may," "will," "should," "believe," "intends" and similar expressions are intended to identify forward-looking information. In respect of the forward-looking information, AgJunction has provided such information in reliance on certain assumptions that it believes are reasonable at this time. Readers should not place undue reliance on such forward-looking information contained in this press release since forward-looking information addresses future events and conditions, such information by its very nature involves inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. This press release is for informational purposes only and does not constitute an offer to sell or a solicitation to buy any security which may be referenced herein.

Lisa Shields AgJunction 480-399-0989 Lshields@agjunction.com Cody Slach Liolios Investor Relations 785-742-2976 AJX@liolios.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Biohaven's BHV-1530 Data Earns a Careful Investor Look

Updated Category News Views 19

Thirty heavily treated cancer patients can make a molecule look brilliant or merely lucky, and BHV-1530 is still living in that uncomfortable early-stage gap. Biohaven presented Phase 1 results at ENA 2026 that deserve real attention, particularly because the responses showed up in patients with few attractive remaining options. But this is not the moment to confuse a...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 21

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Tongwei's 846 MW Romania Deal Tests Solar Supply Scale

Updated Category News Views 74

Eight hundred forty-six megawatts of panels do not quietly roll out the factory gate. Tongwei’s supply agreement with Rezolv Energy for Romania’s Dama Solar project is a hefty piece of utility-scale solar business, and the first truckload has already left Tongwei’s Nantong facility. That matters more than another polished signing-ceremony photo: equipment is moving,...

Continue Reading
NVE Revenue Pull-Forward Raises Hard Investor Questions

Updated Category News Views 50

A Quarter Can Look Great Until It Doesn’t NVE investors got a nasty lesson in revenue timing, the sort that makes even old hands check the fine print twice. On July 22, 2026, the company reported sequential revenue growth of 43% and net-income growth of 23%. The next trading day, shares vaulted $47.53, or 54%. Then came October, and the floor gave way: NVE reported that...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 87

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
Brightstar Picks Warsop for Its Next CEO Chapter Ahead

Updated Category News Views 31

A Handoff With Plenty Riding on the Rails A lottery supplier changing captains is not usually fireworks, but this one deserves a hard look. Brightstar Lottery has named Thomas Warsop to replace Vince Sadusky as chief executive officer and board member effective January 1, 2027. Sadusky is retiring from both posts on that date. The company is telegraphing an orderly baton...

Continue Reading
T. Rowe Price Expands Teams Across 12 Fund Strategies

Updated Category News Views 49

A Quiet Personnel Shift With Real Stakes Twelve strategy changes may sound like administrative wallpaper, but asset managers live and die by who makes the calls. T. Rowe Price is broadening portfolio-management teams across equity and fixed-income offerings while insisting that each strategy's philosophy, process, and risk limits remain intact. Fine. That is the stated...

Continue Reading
Abbe Lane Estate Puts Jewelry Demand on Full Display

Updated Category News Views 101

Glamour Is Walking Back Into the Auction Room Abbe Lane’s jewelry is not being offered as a vague nostalgia exercise; it is arriving with dates, a setting, and a clear split between two December sales. John Moran Auctioneers will lead with The Estate of Abbe Lane on Wednesday, December 9, 2026, at 10:00 a.m. PST, then follow with its Jewelry & Watches auction on...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 217

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading

Top 5 Most Recently Viewed Articles

commercetools Compilations: Innovations Driving Digital Growth

Updated Category News Views 177

Exciting Launch of commercetools Compilations commercetools has unveiled Compilations, a semi-annual showcase that highlights more than 50 product enhancements, demonstrating the organization’s dedication to innovation and improved customer experiences for users of the commercetools Platform. With over 13,000 deployments and 200 releases, this initiative significantly...

Continue Reading
Join the Class Action Against Red Cat Holdings, Inc. Today

Updated Category News Views 185

Understanding the Class Action Against Red Cat Holdings, Inc. Red Cat Holdings, Inc. is currently under the spotlight due to a class action securities lawsuit filed by the law firm Levi & Korsinsky, LLP. The firm is reaching out to investors who believe they have incurred losses due to the alleged securities fraud that transpired between a specified period. If you have...

Continue Reading
GRAIL Initiates Patient Testing with Innovative Blood Test for Lung Cancer

Updated Category News Views 127

GRAIL Announces Milestone in Lung Cancer Detection GRAIL, Inc. (Nasdaq: GRAL), a pioneering healthcare firm focused on early cancer detection, has achieved a significant milestone by announcing that the first patient has been assessed for eligibility through its innovative non-small cell lung cancer (NSCLC) ctDNA Assay. This groundbreaking development occurs within the...

Continue Reading
Neurocrine Biosciences Enhances Collaboration with Takeda

Updated Category News Views 197

Neurocrine Biosciences Enhances Collaboration with Takeda Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has recently announced an amendment to strengthen the strategic collaboration with Takeda. This partnership focuses on the development and commercialization of osavampator, an innovative therapeutic candidate that holds promise for patients suffering from major depressive...

Continue Reading
LivaNova Prepares to Reveal 2024 Year-End Financials

Updated Category News Views 94

LivaNova's Upcoming Financial Announcement LivaNova PLC (Nasdaq: LIVN), a prominent player in the medical technology sector, is gearing up for an important event. The company will hold a conference call in which they will discuss their financial results from the fourth quarter as well as the entire year of 2024. This event is slated for a Tuesday afternoon and is expected...

Continue Reading